Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 3, 2011Lower event rates for new alloy and stent design versus older drug-eluting stent model
Boston Scientific Corporation (NYSE: BSX) today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS...
-
Mar 29, 2011Clinical presentations to include 12-month data on PROMUS Element™ Platinum Chromium Stent
Boston Scientific Corporation (NYSE: BSX) today announced its clinical trial news and events schedule at the 60th Annual Scientific Session of the...
-
Mar 24, 2011New technology designed to improve lead anchoring speed and consistency for physicians
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for...
-
Mar 22, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that it will hold an analyst event on April 4, 2011 at the 60th Annual Scientific Session of...
-
Mar 8, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to present at the Barclays Capital 2011 Global Healthcare Conference in Miami. Jeff Capello,...
-
Mar 7, 2011Third-generation bare-metal stent offers improved acute performance in treating patients with coronary artery disease
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System,...
-
Mar 3, 2011Company adds innovative technology for atrial fibrillation patients with high stroke risk
Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Atritech, Inc. of Plymouth, Minnesota. The completion...
-
Feb 17, 2011Company's third-generation drug-eluting stents now available in rapidly growing market
Boston Scientific Corporation (NYSE: BSX) today announced its launch of the PROMUS® Element™ Everolimus-Eluting Coronary Stent System and TAXUS®...
-
Feb 16, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2011 RBC Capital Markets' Healthcare Conference on March 2 in New York....
-
Feb 15, 2011New products expand treatment options for healthcare providers
Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions...